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Summary
We have previously reported that peripheral blood y/6+ T cells proliferate in high frequency
(1 in 2-20) in response to heat-killed Mycobacterium tuberculosis (M.tb.) . In the present study,
the T cell receptor phenotype of mycobacteria-responsive human y/6+ T cells was analyzed in
primary cultures with a set of monoclonal antibodies (mAbs) directed against Vy9, V61, and
V62 . When unseparated T cells were stimulated with M.tb., all proliferating 'y/6+ T cells
expressed Vy9 (and V62) after culture. Selective depletion of Vy9-bearing cells before culture
completely abolished the proliferative response of all y/6+ T cells (but did not inhibit reactivity
ofa/R+ T cells) . In addition, when CD4-CD8- thymocytes were stimulated with M.tb., there
was again selective outgrowth of Vy9+ cells. In this case, the starting responder population
contained few (0.5-1.8%) Vy9+ and many (11.5-31.5%) V61+ cells that did not coexpress Vy9 .
These V61+ cells were not activated byM.tb. but could be readily stimulated by antiV61 mAb
A13 . Finally, a Vy9-specific mAb selectively suppressed the proliferative response of .y/6+ T
cells to M.tb. Taken together, our results demonstrate that, within y/6+ T cells, reactivity
towards M.tb . is an exclusive property of Vy9+/V62+-bearing cells .
minor subset ofhuman and murine T cells expresses a
1 -1TCR composed ofy and 6 chains (1-7) . y/6+ T cells
account for 1-10% of CD3+ peripheral blood T cells, and
appear to be evenly distributed throughout the lymphoid tissue
inhumans (6-9) . In striking contrast to the TCR-oi/a there
is only a small number of functional Vy and V6 gene seg-
ments, which results in limited germline diversity of theTCR
y/6 when compared with theTCRci/a (6, 7, 10) . In addi-
tion, it appears that only a few of the available Vy and V6
segments are actually used to construct the expressed TCR-
y/& Thus, >60% ofhuman peripheral blood y/6+ T cells
express aVy9 (nomenclature ofVy genes according to refer-
ence 10a) chain paired with a 6 chain using theV62 element
(11-15) . The second most frequent (10-20%) subset of pe-
ripheral blood y/6+ T cells utilizes aV61 gene segment that
is usually paired with aVy element other than Vy9 (14-17) .
The extensive occurrence of Vy9 paired with V62 among
peripheral bloody/6+ T cells is not genetically determined,
because Vy9+/V62+ cells constitute only a minor fraction
of y/6+ T cells in postnatal human thymus (9, 18) . In ad-
dition, the molecular analysis of a large number of human
thymic y/6+ clones did not reveal any evidence for the selec-
tiveVy9/V62 pairing as being due to constraints at the level
ofDNA rearrangements or protein pairing (19) . It is thus
possible that the extrathymic expansion of Vy9+/V62+ T
cells in human peripheral blood is driven by specific antigenic
pressure (18-20) .
The nature of the ligands recognized by y/6+ T cells re-
mains elusive (7, 21, 22) . A striking feature of both murine
and human y/6+ T cells, however, is their frequent reac-
tivity towards mycobacterial antigens, including in some cases
the 65-kD mycobacterial heat shock protein (hsp)t (23-29) .
We and others have shown that human peripheral blood
y/6+ T cells proliferate in high frequency in response to
killed mycobacteria (30, 31) . The surprisingly high frequen-
cies of mycobacteria-reactive y/6+ cells (1 in 2-20) measured
in our previous study (30) suggested that a major fraction
of all peripheral blood y/6+ T cells was activated by killed
Mycobacterium tuberculosis (M.tb .) bacteria . The present ex-
periments were designed to identify the mycobacteria-reactive
subset of human y/6+ T cells .
1 Abbreviations used in this paper . DN, double negative ; hsp, heat shock
protein; MACS, magnet-activated cell sorter ; MNC, mononuclear cell ;
M.tb., Mycobacterium tuberculosis; NA, nonadherent ; SEA, staphylococcal
enterotoxin A .
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Isolation of Lymphocyte Sulpopulations.
￿
PBMC from normal
donors were isolated by Ficoll-Hypaque density gradient centrifu-
gation . Monocytes/macrophages were removed from PBMC by
plastic adherence for 60 min at 37°C . T cells were purified from
plastic-nonadherent (NA) cells by theErosettemethod as described
(30) . V-y9-expressing y/S + T cells were depleted from either NA
or separated T cells by FACS® (Becton Dickinson&Co., Moun-
tain View, CA) using mAb 7A5 developed in our laboratory.mAb
7A5 precipitates theTCR solubilized from the surface membrane
of cloned y/6+ T cells (32) . As tested on a large panel of y/6+
clones, its specificity is identical to mAb TiyA, which has been
shown to recognizeaVy9-encoded epitope (11) .The Vy9 specificity
of mAb 7A5 has been confirmed by molecular analysis of 7A5
clones(M.B. BrennerandH. Band, personal communication) . NA
orT cells were incubated for20 min on ice with biotinylatedmAb
7A5 . After being washed, cells were incubated with PE-labeled
streptavidin (Becton Dickinson & Co .) as a second-step reagent .
7A5- and 7A5+ subsets were sorted on a FACStar Plus* cell
sorter (Becton Dickinson & Co .) based on forward light scatter
and fluorescence intensity . Dead cells were excluded by propidium
iodide staining. In some experiments, 7A5+ cells were depleted by
using a magnet-activated cell sorting device (see below) .
Samples ofpostnatalthymus tissue were obtained from children
undergoing corrective heart surgery, and were kindly made avail-
able through Prof. S. Hagl (University of Heidelberg) . Thymus
tissue was minced, andthe single cell suspension was subsequently
centrifuged on Ficoll-Hypaque gradients . CD4 -CD8- double-
negative (DN) cells were enriched from thymus mononuclear cells
(MNC) by depleting most CD4+ and CD8+ cells by means of a
magnet-activated cell sorter(MACS ; Miltenyi Biotechnik, Bergisch-
Gladbach, Germany) . To this end, thymusMNC were incubated
with saturating amountsofbiotinylated anti-CD4(OKT4;Amer-
ican Type Culture Collection [ATCC], Bethesda, MD) plus bio-
tinylated anti-CD8 (OKT8 ; ATCC) mAbs . After being washed,
the cells were incubated for additional 20 min with biotinylated
goat anti-mouse IgG (Tago, Inc ., Burlingame, CA) . After two
washing steps, FITC-labeled avidin (Dianova GmbH, Hamburg,
Germany) was added as a second-step reagent, and incubation was
continued for20 min on ice . The cellswere washed, resuspended
on ice in biotinylated magnetic beads, and passed through a mag-
netic column .
Cell Cultures.
￿
Responder cells were cultured in round-bottomed
microtiter plates (Nunc, Roskilde, Denmark) at 5-10 x 104 cells
per well . The culture medium was RPMI 1640 (Biochrom KG,
Berlin, Germany) supplemented with 2MM L-glutamine, antibi-
otics, 10mM Hepes, and 10% heat-inactivated male human serum .
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In most experiments, 105 irradiated (2,000 rad from a cesium
source) autologousPBMC were added asAPC . In the case ofthymo-
cyte responder cells, allogeneic irradiatedPBMC were used asAPC.
The following stimuli were included to activate restingT cell . PHA-
P(Wellcome, Burgwedel, Germany) at 0.5 Ftg/ml, anti-CD3mAb
OKT3 (Cilag AG, Sulzbach, Germany) at 1 ug/ml, allogeneic ir-
radiated PBMC stimulator cells at 105 cells per well, or 0.01%
(vol/vol) of a suspension of killedM.tb . strain H37RV Mycobac-
teria were autoclaved for 20 min at 120°C, sonicated for 15 min,
and stored at -70°C . Immediately before use, bacteria were again
sonicated for 5 min . In some experiments, DN thymocytes were
stimulated with soluble antiV61 mAb A13 (ascites diluted at 1:2,000
final; see below) . Allcultures were incubated at 37°C in a humidified
atmosphere of 5% CO Z in air. Where indicated, 1 ng/ml rIL2
(EuroCetus, Amsterdam, The Netherlands) was added after 3 d
(see Results) . After 3-8 d of culture, 1 g.Ci [3H]TdR (sp act, 6.7
Ci/mmol) was added per microculture, and incubation was con-
tinued for another 6 h. Cell cultures were harvested and prepared
for counting in a liquid scintillation counter as described (30) .
Results are presented as mean cpm of triplicate cultures . SD were
always <15% .
Phenotypic Analysis ofFresh and CulturedT Cells.
￿
The following
mAbs were used to characterize the expressedTCRon T cells be-
fore and after culture. BMA031 (TCRa/S; reference 33), TCR-
S1 (Ca ; references 18 and 34), SrCS1 (V61J61, V61J62 ; reference
35), A13 (V61 ; reference 36), BB3 (V62; reference 15), 7A5 (Vy9 ;
reference 32). In indirect staining procedures, FITC-conjugated
F(ab)z goat anti-mouse IgG (Tago, Inc.) wasused as a second-step
reagent . Commercial mAbs (TCR61, 8rCS1; both from T Cell
Sciences, Cambridge,MA)were used as FITC conjugates. In two-
color analyses, biotinylated 7A5 mAb was visualized with PE-
streptavidin. After being stained, all samples were resuspended in
1% paraformaldehyde. All analyses were measured on aFACScana
cytofluorometer (Becton Dickinson & Co.) .
Results
Stimulation of UnseparatedT Cells withMA Induces Selec-
tive Expansion of Vy9+/V82+ Cells. We and others (30,
32) have recently reported that stimulation ofunfractionated
peripheral bloodT cells (containing from 0.5 to 8% y/6+
T cells) with killed M.tb. preferentially triggers the activa-
tion of y/b+ T cells, thus giving rise to a population of
40-90% y/b+ T cells after 6-9 d of culture . We have now
explored theTCR phenotype ofM.tb.-stimulated -y/6+ T
cellswith mAbs directed against variable regions ofy (Vy9 :
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Figure 1 .
￿
TCR phenotype of PBMC after stimulation with M.tb . PBMC containing 0.3% .y/6+ (TCRSl+) T cells were cultured with M.tb.
(1437) . After9 d, proliferating cells were stained with the indicatedmAbs and analyzed on aFACScan® . x-axis represents log green fluorescence (FITC) ;
y-axis indicates log red fluorescence (PE) .mAb 7A5) and S chains (V61 : mAbMl ; Vb2 : mAb BB3) .
Results of a representative two-color cytofluorimetric anal-
ysis are shown in Fig . 1 . Before culture, PBMC responder
cells consisted of 90.0% a/#+ and 0.3% y/6+ T cells .
After culture for 9 d withM.tb ., 42.6% ofproliferating cells
were a/,6+, whereas 45.0% were .-y/6+ . Importantly, all
y/6+ T cells after culture expressed the Vy9 epitope as
shown by two-color staining with mAbs TCR-61 and 7A5
(Fig. 1) . Further two-color analyses revealed that all Vy9+
(7A5+) cells coexpressed the BB3 (V62) epitope (Fig. 1) but
failed to stain with mAb MCS1 (V61) (Fig. 1) . Qualitatively
identical results were obtained in six additional experiments .
Depletion ofVy+ Cells Abrogates the -y/a+ T Cell Response
to M.th It is well established that Vy9+/V62+ cells ac-
count for a major fraction (N60-70%) of adult peripheral
blood y/6+ T cells, while the mutually exclusive subset of
V61+ cells represents N10-20% of peripheral y/b+ T cells
(17) . To address the issue of whether the selective growth
of Vy9+ cells after M.tb. stimulation was simply due to
Vy9+ cells outnumbering V61+ cells severalfold in the
starting population, we performed depletion experiments in
which Vy9+ cells were selectively removed from E-rosetted
T cells by MACS or FRCS® cell sorting. As detailed in Table
1, the starting population ofNA or E-rosetted T cells con-
sisted of 61.4-89.3% a/a+ T cells and 3.5-8.1% y/6+ T
cells, of which a major fraction was 7A5+ . Depletion of
7A5+ cells by MACS or FACS® resulted in cell populations
with greatly diminished, yet detectable numbers (0.2-4.0%)
of y/6+ cells as revealed by staining with mAb TCR-61 .
Reanalysis of sorted cells ensured that Vy9+ (7A5+) cells
were efficiently depleted . As expected, the majority of re-
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maining y/6+ cells was 6TCS1+ . When unfractionated T
cells (E+ or NA) and 7A5-depleted cells (E+/7A5 - or NA/
7A5 - ) were stimulated with M.tb., dramatic differences
were observed with respect to the TCR phenotype ofprolifer-
ating cells . As noted in previous experiments, a large frac-
tion (42.8-88.1%) of unseparated responder cells displayed
the 7A5 +/bTCS1 - phenotype after culture with M.tb .,
while the percentage of a/a+ cells ranged from only
9.5-54.0% . As reported in Table 1, depletion of 7A5+ cells
before culture withM.tb. completely abolished the Prolifer-
ative response of all y/6+ T cells, thus giving rise to cell
populations that were predominantly (63 .5-97.7%) a/(3+,
with only minor contaminations (0.1-2.3%) of y/6 + T
cells. Note that this was also true when the unfractionated
T cell population contained unusually high numbers of
Vy9 -/V61+ (7A5 -/bTCS1+) y/6+ T cells, such as in exp.
3 of Table 1 . Here, the 7A5-depleted T cells still contained
4.0% y/6+ cells, of which 3.7% were MCS1+ . These cells
were unable, however, to proliferate in response to M.tb.
Thus, the phenotypic analysis of cultured cells revealed the
proliferation of exclusively a/(3+ T cells with negligible
contamination (0.3%) by 6TCS1+ y/6+ T cells.
Anti-Vy9 mAb 7A5 Inhibits the Proliferative Response to
M.th The next experiments were aimed at analyzing whether
the selective activation of Vy9+ T cells was initiated
through TCR-dependent recognition ofM.tb . . To this end,
the effect ofantiVy9 mAb 7A5 on the activation of PBMC
responder cells byM.tb.,PHA, or allogeneic stimulator cells
(MLR) was investigated. As shown in Fig. 2, mAb 7A5 in-
hibited in a dose-dependent manner specifically the response
ofPBMC (containing 2.3% 7A5+ cells) toM.tb ., while it
E-rosetted T cells (E+; exp . 1-4) or plastic-nonadherent cells (NA + ; exp . 5) were depleted of 7A5+ .y/6+ T cells by MACS (exp . 1) or FACS®
(exp. 2-5), and cultured with autologous PBMC feeder cells andM.tb . [3H]-TdR uptake was determined after 4-6 d. The TCR phenotype was
analyzed before (day 0) and after culture (days 6-9) with the indicated mAbs.
Table 1 . Depletion of 7A5+ (Vy9 .
) T Cells Abrogates the Proliferative Response of all y/a+ T cells to Mtb.
Phenotype (day 0) Phenotype after culture (days 6-9)
Exp . Responder BMA031+ TCR-61+ 7A5+ 6TCS1+ BMA031+ TCR-61+ 7A5+ STCS1+
q
1 E + 78.3 7.4 7.2 1 .2 26.5 69.9 69.6 0.1
E+/7A5- 83.6 1 .2 0.1 1 .2 84.1 2.3 1.4 0.8
2 E + 85.5 5.4 5.0 0 15.8 79.4 79.2 0.1
E+/7A5- 90.2 0.3 0.1 0.1 74.8 0.1 0 0.1
3 E + 83.5 8.1 4.8 3.0 54.0 44.7 42.8 0.3
E+/7A5- 86.2 4.0 0 3 .7 97.7 0.5 0.9 0.3
4 E + 89.3 3.5 2.9 0.2 11 .7 87.8 88.1 0
E+/7A5- 80.7 0.5 0 0.3 83.5 0.2 0 0.2
5 NA 61.4 4 .8 4.8 0 9.5 83.0 81.1 0
NA/7A5 - 70.2 0.2 0 0.1 63.5 0.1 0 0d
>n
c 0
0
MNC
DN
0 0.01 0.1
Figure 2 .
￿
Inhibition of M.tb. reactivity by anti-V-y9 mAB 7A5 . 105
PBMC (containing 3.2% TCRS1+ and 2.3% 7A5+ cells) were cultured
per microwell with 105 irradiated allogeneic PBMC stimulator cells
(MLR),PHA (0.5 .ug/ml), orM.tb. (H37) . mAb 7A5 was added as indi-
cated . [ 3H]TdR uptake was determined after 3 d (PHA) or 5 d (MLR ;
H37) . Mean control cpm of triplicate cultures in the absence ofmAb were
as follows : PHA, 77,100 cpm ; MLR, 22,000 cpm ; H37, 51,500 cpm .
did not have any inhibitory effect onPHA or MLR responses .
In additional experiments (data not shown), time course ki-
netics revealed significant [ 3H]TdR incorporation also in the
presence of 7A5 (1 Ag/ml) inM.tb.-stimulated cultures at
BAS jig/ml
Figure 3 .
￿
Phenotypic characterization of freshly isolated unseparated and CD4-CD8- double-negative thymocytes . Thymus (sample A140) MNC
and DN cells were stained with the indicated mAbs and analyzed on a FACScang . x-axis indicates log green fluorescence (FITC) ; y-axis indicates
log red fluorescence (PE) .
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later time points (day 7) . As shown by phenotypic analysis,
however, the vast majority ofM.tb.-stimulated T cells cul-
tured in the presence of mAb 7A5 were a/(3+ .
MA Selectively Triggers Vy9+/Va2+ Cells among CD4 -
CDS- Thymocytes . The above experiments with unsepa-
rated and Vy9-depleted peripheral bloodT cells showed that
Vy9+ but not VSl+ -y/S+ T cells proliferate in response to
M.tb. stimulation. The strength of this argument is weakened,
however, by the fact that very few (0.1-3.7% ; Table 1) VSl+
cells remain among peripheral blood T cells after removal
ofVy9+ cells; therefore, it may be argued that, for technical
reasons, these few VS1+ y/S+ T cells could not be activated
under our culture conditions . To definitively prove that re-
sponsiveness to M.tb. is an exclusive property of Vy9+ and
not of VSl+ cells among y/S+ T cells, we resorted to re-
sponder cell populations where the Vy9/VSl ratio usually
found in adult peripheral blood (4-6:1) is inversed . To this
end, CD4 -CD8- double-negative cells were enriched from
thymus MNC obtained from three children undergoing cor-
rective heart surgery. A comparative phenotypic analysis of
MNC and DN cells from a representative thymus is shown
in Fig. 3 . Unfractionated thymus MNC contained 68.1%
ca/(3+ and 0.5% y/S+ T cells . After MACS depletion of
most CD4+ and CD8+ cells, the remaining DN cells con-
tained 5.1% a/R+ and 21.8% y/S+ . In line with published
reports (18), the majority (13.5%) of DN y/6+ cells were
$1'CS1+, while only a minor fraction (1.7%) expressed the
Vy9-encoded 7A5 epitope. In contrast to adult peripheral
blood, 7A5+/STCS1+ double-positive cells were readily de-
tectable (3.1% ; Fig. 3) . WhenDN thymocytes were culturedalloll
+ H37
allo h
+ A13
in the presence ofallogeneic feeder cells and exogenous IIr2,
cant proliferation was observed (data not shown) . Under
these conditions, the relative proportion of 7A5+ and
6TCS1+ after 8 d of culture did not change; i.e., 6TCS1+
were far in excess (28.2%) of 7A5+ cells (2.2% ; Fig . 4, top
row) . Quite different results were obtained whenM.tb. was
added at the initiation of culture. In this case, the pheno-
typic analysis of cultured cells revealed the presence of large
numbers of 7A5+ cells (74.9%), while the percentage of
V61+ cells was as low as 4.5% (Fig. 4, middle row) . In ac-
cordance with results obtained with peripheral blood cells,
the vast majority of 7A5+ DN thymocytes stimulated by
M.tb. coexpressed the BB3 (Vb2) epitope (see Fig. 4, middle
row) ; the very few 7A5+/6TCS1+ cells detected afterM.tb .
stimulation were most likely derived from the few
7A5 +/bTCS1 + cells present in the starting population
(compare Figs . 3 and 4) . In the experiment shown in Fig .
4, an aliquot ofDN thymocytes was also cultured with al-
logeneic feeder cells and antiV61 mAb A13 (36) to selec-
tively trigger the activation ofV61 + T cells . As can be seen
in Fig. 4 (bottom row), this protocol resulted in the preferen-
tial expansion of two subsets of V61+ subsets that did
(21.9%) or did not (52.0%) express the Vy9 epitope. In
striking contrast toM.tb.-stimulated cultures (Fig . 4, middle
row), V62+ (BB3+) y/6+ T cells were at almost undetect-
able levels (<I%) in A13-stimulated cultures . Comparable
results were obtained with the other two thymus samples .
It is thus clear that the failure of V61 + cells to proliferate
in response toM.tb. stimulation is not due to a general lack
of responsiveness to activation signals of V61 + cells .
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Discussion
Figure 4.
￿
Phenotypic character-
ization ofCD4-CD8- thymocytes
after culture. 5 x 104 thymus DN
cells (sample A140) were cultured
per microwell with 105 irradiated
allogeneic PBMC feeder cells in the
absence (top row) or presence of
M.tb. (H37; middlerow) or antiV61
mAb A13 (bottom row) . After 2 d,
rIL2 (1 ng/ml) was added to all cul-
tures. On day 12, the proliferating
cells were analyzed by two-color
analysis using the indicated combi-
nations of mAbs directed against
TCRct/0 (BMA031), TCRy/6
(TCR61), Vy9 (7A5), V61(6TCS3),
and V62 (BB3). x-axis indicates log
green fluorescence(FITC) ; y-axisin-
dicates log red fluorescence (PE) .
A striking feature y/6+ T cells is their frequent reactivity
towards mycobacterial antigens (23-31) . The high frequen-
cies of mycobacteria-reactive y/6+ T cells determined in our
previous study (30) suggested that this reactivity might be
a property of a major proportion ofperipheral blood y/6+
T cells. Therefore, we attempted to characterize the respon-
sive subset with the aid ofVy9-, V61-, and V62-specific mAbs.
To ensure that the results would be representative for the whole
population of y/6+ T cells, we investigated the reactivity
of unmanipulated primary (i.e., polyclonal) cells rather than
that of individual established clones . We found that all y/6+
T cells proliferating in response to killedM.tb. coexpressed
Vy9+ and V62+ . More importantly, T cells selectively
depleted of Vy9-bearing cells before culture (yet still con-
taining other subsets ofy/6+ cells such as V61+) prolifer-
ated vigorously after stimulation withM.tb . In this case, how-
ever, the response was mediated exclusively by a/g+ T cells
(with some contribution of CD2+CD3 - cells), indicating
that V61+ cells were nonresponsive to M.tb. The failure of
V61+ cells to respond to M.tb. stimulation was even more
obvious when CD4-CD8 - thymocytes were analyzed..
Coculture ofDN thymocytes with M.tb. again resulted in
the preferential outgrowth of Vy9+/Vb2+ cells, although
these cells were present in only small numbers in the starting
responder population . In contrast, V61 + cells accounting for
a major proportion ofy/6+ T cells amongDN thymocytes
did not expand in response toM.tb. stimulation . These cells
could be activated, however, by soluble antiV61 mAb A13
(Fig. 4), indicating that V61+ thymocytes are not generallyrefractory to activation stimuli. Therefore, we conclude that
the proliferative response of primary human -y/b+ T cells
to killed M.tb. is an exclusive property ofVy9-bearing cells.
A similarly limited receptor repertoire of purified protein
derivative--reactive -y/b+ T cells has been previously observed
with hybridomas derived from newborn murine thymus (37).
However, it cannot be inferred from our data that the an-
timycobacteria reactivity of human Vy9+ cells is an (oligo)
clonal response. Despite the limited germline diversity of
mycobacteria-responsive Vy and VS TCR elements, it is pos-
sible that the proliferating Vy9+ cells display significant
diversity in the junctional regions between V and J (for the
y chain), and V and D, D and D, and D and J (for the S
chain) . To address this issue, junctional regions of a large
number of M.tb.-reactive Vy9+/Vb+ clones will have to be
sequenced (20).
Our study has not addressed the nature of the mycobac-
terial antigen(s) or ligand(s) that stimulate Vy9+ human T
cells. In this context, it is of interest that others have described
protease-resistant low molecular weight fractions ofmycobac-
terial cell lysates that exclusively stimulate y/b+ but not
a/R+ T cells (31). Apart from mycobacterial ligands, two
other antigens that selectively activate Vy9-bearing T cell
clones have recently been described. Fisch et al. (38) reported
that all of their tested Vy9+ clones specifically lysed Daudi
but not Raji target cells, whereas simultaneously derived
CD3/TCR- NK clones lysed both targets. Furthermore,
Rust et al. (39) demonstrated that cytotoxic effector activity
of all analyzed Vy9-bearing clones could be triggered by
staphylococcal enterotoxin A (SEA), whereas Vy9 - y/b+
References
clones were resistant to SEA stimulation. Takentogether with
our present results, it appears that at least three seemingly
different ligands (killed mycobacteria, Daudi tumor cells, and
SEA) are recognized by most if not all Vy9+ cells. Stimu-
lation of the whole y/b+ T cell subset expressing a
Vy9+/Vb2+ receptor by a given ligand is reminiscent of the
recently described "superantigen" reactivityofa/a+ T cells
bearing a particular Va (40). Further studies are required to
investigate the nature of the mycobacterial ligand that acti-
vates Vy9-bearing cells. Based on our previous results (30)
and those obtained by others (31), it is unlikely that the 65-
kD hsp is the major Vy9-stimulating antigen. As shown in
Fig. 2, antiVy9 mAb 7A5 efficiently blocked the primary
response of -y/b+ T cells to M.tb. Although no formal
proof, this is strong evidence that activation was mediated
through TCRdependent ligand recognition, and not simply
through TCRindependent mitogenic effects. However, in
view of our recents results that mAb 7A5 can induce pro-
grammed cell death (apoptosis) in IL-2-dependent 7A5+
clones (32), we cannot exclude the possibility that 7A5 killed
MA.-reactive Vy9+ cells shortly after activation.
In conclusion, we have shown that the primary response
of peripheral blood and thymus -y/b+ T cells to killed
mycobacteria is an exclusive property of Vy9-bearing cells
that coexpress Vb2. In view of the fact that Vy9+/Vb2+
cells dominate in adult peripheral blood but neither in cord
blood nor in postnatal thymus (18), our results support the
hypothesis that the extrathymic expansion of this particular
-y/b+ subset might be due to postnatal exposure to certain
bacterial antigens such as M.tb. or SEA (39).
We thank Drs. T Hercend, R. Kurrle, L. Moretta, and F. Triebel for their generous gifts of antibodies,
and Prof. S. Hagl (Dept. ofSurgery, University ofHeidelberg) for providing specimens of human thymus.
We also thank Prof. H. G. Sonntag and Mrs. Roswitha Restorff(Dept. ofMedical Microbiology, Univer-
sity of Heidelberg) for providing cultures of M. tuberculosis strain H37RV The expert technical assistance
of Susanne Schondelmaier and Ann Atzberger is gratefully acknowledged.
This work was supported by the Bundesministerium fur Forschung and Technologie (01 ZU 8601). Dieter
Kabelitz was supported by the Alfried Krupp Award for young professors.
This work forms part of the Ph.D. thesis of Anke Bender.
Address correspondence to Dieter Kabelitz, Institut fur Immunologie, Universitat Heidelberg, Im Neuen-
heimer Feld 305, D-6900 Heidelberg, FRG.
Receivedfor publication 26 November 1990 and in revised form 11 February 1991.
1. Brenner, M.B., J. McLean, D.P. Dialynas, J.L. Strominger, J.A.
Smith, F.L. Owen, J.G. Seidman, S. Ip, F. Rosen, and M.S.
Krangel. 1986. Identificationof a putative second T -cell receptor.
Nature (Lond.). 322:145.
2. Maeda, K., N. Nakanishi,B.L. Rogers, W.G. Haser, K. Shitara,
H. Yoshida, Y. Takagaki, A.A. Augustin, and S. Tonegawa.
1987. Expression of the Tcell receptor y-chain gene products
3 .
1336
￿
Mycobacteria-reactive ti/S' T Cells Express Vy9
on the surface of peripheralT cells and T-cell blasts generated
by allogeneic mixed lymphocyte reaction. Proc Nad. Acad. Sci.
USA. 84:6536.
Borst, J ., R.J. van de Griend, J .W. van Oostveen, S.-L. Ang,
C.J. Melief,J.G. Seidman, and R.L.H. Bolhuis. 1987. A Tcell
receptor .y/CD3 complex found on cloned functionallympho-
cytes. Nature (Lond.). 325:683 .4 . Moingeon, P., S . Jitsukawa, F . Faure, F . Troalen, F . Triebel,
M. Graziani, F . Forestier, D. Bellet, C. Bohuon, andT Her-
cend. 1987 . Ay-chain complex forms a functional receptor on
cloned human lymphocytes with natural killer-like activity.
Nature (Lond.). 325:723 .
5 . Brenner, M.B., J . McLean,H. Scheft,J . Riberdy, S.-L. Ang,
J.G . Seidman, P . Devlin, andM.S . Krangel. 1987 . Two forms
of theT -cell receptoryprotein found on peripheral blood cyto-
toxic T lymphocytes. Nature (Lond .). 325:689 .
6. Brenner,M.B., J.L . Strominger, andM.S . Krangel . 1988 . The
-yb T cell receptor. Adv . Immunol. 34:133 .
7. Raulet, D.H. 1989 . The structure, function, and molecular
genetics of they/ST cell receptor. Annu . Rev . Immunol. 7:175 .
8. Groh, V., S . Porcelli, M. Fabbi, L.L . Lanier, L.J. Picker, T
Anderson, R.A . Warnke, A.K . Bhan, J.L . Strominger, and
M.B. Brenner. 1989 . Human lymphocytes bearing T cell
receptor y/S are phenotypically diverse andevenly distributed
throughout the lymphoid system . J . Exp: Med. 169:1277.
9. Falini, B., L. Flenghi, S . Pileri, P. Pelicci, M. Fagioli, M.F .
Martelli, L. Moretta, and E. Ciccone. 1989 . Distribution of
T cells bearing different forms of theT cell receptor y/S in
normal and pathological human tissues.J. Immunol. 143:2480.
10 . Strominger, J.L . 1989 . The y/S Tcell receptor and class Ib
MHC-related proteins : enigmatic molecules of immune rec-
ognition . Cell. 57:895 .
l0a.Lefranc, M.-P., and TH . Rabbits . 1989 . The Human Tcell
receptor y (TRG) genes. Trends Biochem . Sci. 14:214 .
11 . Triebel, F ., F . Faure,M. Graziani, S . Jitsukawa,M.P. Lefranc,
andT Hercend . 1988 . A unique V+C-rearranged gene en-
codes a yprotein expressed on the majority of CD3 * T cell
receptor cx/J3- circulating lymphocytes .J Exp. Med. 167:694.
12 . Borst,J., A. Wicherink, J.J.M . vanDongen,E. De Vries,WM .
Comans-Bitter, F . Wassenaar, andP . Vanden Elsen . 1989 .Non-
random expression of T cell receptor y and S variable gene
segments in functional T lymphocyte clones fromhuman pe-
ripheral blood . Eur . J Immunol. 19:1559 .
13 . Triebel, F., F . Faure, F. Mami-Chouaib, S . Jitsukawa, A.
Griscelli, C. Genevee, S . Roman-Roman, andT Hercend . 1988 .
Anovelhuman VS gene expressedpredominantlyin theTiyA
fraction of -y/S+ peripheral lymphocytes. Eur . J. Immunol.
18:2021 .
14 . Faure, F., S.Jitsukawa, F . Triebel, andT Hercend . 1988 . Char-
acterization of human peripheral lymphocytes expressing the
CD3-y/Scomplex with anti-receptormonoclonal antibodies.
J Immunol. 141:3357 .
15 . Bottino, C., G . Tambussi, S . Ferrini, E. Ciccone, P . Varese,
M.C . Mingari,L. Moretta, andA. Moretta . 1988 .Twosubsets
ofhumanT lymphocytes expressing y/6 antigen receptor are
identifiable by monoclonal antibodies directed to two distinct
molecular forms of the receptor. J. Exp. Med. 168:491 .
16 . Sturm, E., E. Braakman, R.E . Bontrop, P . Chuchana, R.J .
Vande Griend, F . Koning,M.-P. Lefranc, andR.L.H. Bolhuis.
1989 . Coordinated Vy and VS gene segment rearrangements
in humanT cell receptor ^t/S+ lymphocytes . Eur .J Immunol.
19:1261 .
17 . Tribel, F., andT Hercend . 1989 . Subpopulations of human
peripheralT gamma delta lymphocytes . Immunol. Today. 10:186 .
18 . Parker, C.M ., V Groh, H. Band, S.A . Porcelli, C. Morita,
M. Fabbi, D. Glass, J.L . Strominger, andM.B. Brenner. 1990 .
Evidence for extrathymic changes in the T cell receptor y/S
repertoire. J Exlz Med. 171:1597 .
19 . Casorati, G., G. de Libero, A. Lanzavecchia, andN. Migone.
1989 . Molecular analysis of human y/S* clones from thymus
1337
￿
Kabelitz et al.
and peripheral blood.J . Exp, Med . 170:1521.
20. Tamura,N., K.J . Holroyd, TBanks,M. Kirby,H. Okayama,
andR.G . Crystal 1990. Diversity in junctional sequences as-
sociated with the common human Vy9 and V62 gene seg-
ments in normal blood and lung compared with the limited
diversity in a granulomatous disease.J . Exp. Med. 172:169 .
21 . Bluestone, J.A., and L.A . Matis. 1989 . TCR-,yb cells : minor
redundantT cell subset or specialized immune system compo-
nent?J Immunol. 142:1785 .
22 . Raulet,D.H . 1989 . Antigens for y/6T cells. Nature (Lond .).
339:342.
23 . Janis, E.M ., S.H.E . Kaufmann, R.H . Schwartz, and D.M .
Pardoll. 1989 . Activationofy6T cells in theprimary response
to Mycobacterium tuberculosis . Science (Wash . DC). 244:713 .
24 . O'Brien, R.L ., M.P. Happ, A. Dallas, E. Palmer,R . Kubo,
and WK . Born . 1989 . Stimulation of a major subset of lym-
phocytes expressing T cell receptor yb by an antigen derived
from Mycobacterium tuberculosis . Cell. 57:667 .
25 . Yoshikai, Y, G. Matsuzaki, T Inoue, andK. Nomoto. 1990 .
An increase in number of Tcell receptor y/6-bearing T cells
in athymic nude mice treated with complete Freund's adju-
vants . Immunology. 70:61 .
26 . Augustin,A.,R.T. Kubo, andG.-K . Sim. 1989 . Resident pul-
monary lymphocytes expressing the y/S Tcell receptor. Na-
ture (Lond.) . 340:239 .
27. Holoshitz, J., F . Koning, J.E . Coligan, J . de Bruyn, and S .
Strober . 1989 . Isolation ofCD4-CD8- mycobacteria-reactive
Tlymphocyte clones from rheumatoid arthritis synovial fluid .
Nature (Lon4 339:226 .
28 . Modlin,R.L ., C. Pirmez, F.M .Hofman,V Torigian,K. Uye-
mura,TH . Rea, B.B. Bloom, andM.B. Brenner . 1989 . Lym-
phocytes bearing antigen-specific yS Tcell receptors accumu-
late in human infectious disease lesions . Nature(Lon4 339:544 .
29 . Haregewoin,A., G. Rman, R.C. Holm, andR.W. Finberg .
1989. Human yS * T cells respond to mycobacterial heat-
shock protein . Nature (Lon4 340:309 .
30 . Kabelitz,D .,A. Bender, S. Schondelmaier, B. Schoel, andS.H.E .
Kaufmann . 1990 . A large fraction of human peripheral blood
-y6* T cells is activated by Mycobacterium tuberculosis but not
by its 65-kD heat shock protein . J. Expt Med. 171:667 .
31 . Pfeffer, K ., B . Schoel, H. Gulle, S.H.E . Kaufmann, and H.
Wagner. 1990 . Primary responses of human T cells to mycobac-
teria : a frequent set of y/6 T cells are stimulated by protease-
resistant ligands . Eur.J Immunol. 20:1175 .
32 . Janssen,O ., S . Wesselborg, B . Heckl-Ostreicher,K . Pechhold,
A. Bender, S . Schondelmaier, G. Moldenhauer, andD . Kabelitz .
1991 . Tcell receptor/CD3-signalling induces death by apop
tosis in human Tcell receptor yS-positive Tcels .J Immunol.
146:35 .
33 . Kurrle,R ., E.J. Kanzy, J . Racenberg,W Lang, and F.R . Seller .
1989 . BMA 031 - A TCR-specific monoclonal antibody for
clinical application. Transplant. Proc 21:1017.
34 . Band,H., F . Hochstenbach, J . McLean, S . Hata,M.S. Krangel,
andM.B. Brenner. 1987 . Immunochemicalproofthat a novel
rearranging gene encodes theTcell receptor S subunit . Science
(Wash . DC). 238:682 .
35 . Wu, Y.J., Wk.-T. Tian, R.M. Snider, C . Rittershaus, P .
Rogers, L. LaManna, and S.H . Ip. 1988. Signal transduction
of y/ST cell antigen receptor with a novel mitogenic anti-S
antibody. J. Immunol . 141:1476 .
36 . Ferrini, S., I . Prigione,C. Bottino, E. Ciccone,G . Tambussi,
S. Mammoliti, L. Moretta, andA. Moretta. 1989 . Monoclonal
antibodies which react with theT cell receptor y/Srecognizedifferent subsets ofCD3 + WT31 - T lymphocytes . Eur .J Im-
munol. 19:57 .
37 . Happ, M.P., R.T. Kubo, E. Palmer, WK . Born, and R.L .
O'Brien . 1989 . Limited receptor repertoire in a mycobacteria-
reactive subset of-y6 Tlymphocytes. Nature (Lond.) . 342:696 .
38 . Fisch, P.,M. Malkovsky, E. Braakman,E. Sturm, R.L . Bolhuis,
A. Prieve,J.A . Sosman, V.A . Lam, andP.M. Stobe1.1990 . .y/6
T cell clones and natural killer cell clones mediate distinct pat-
1338 Mycobacteria-reactive .y/64 T Cells Express V'y9
terns of non-major histocompatibility complex-restricted cy-
tolysis.J . Exp . Med . 171:1567 .
39 . Rust,QJ., J., F . Verreck, H. Vietor,andF . Koning.1990. Specific
recognition of staphylococcal enterotoxin AbyhumanT cells
bearing receptors with theVy9region . Nature(Lond.) . 346:572 .
40 . Marrack, P ., and J . Kappler. 1990 . The staphylococcal en-
terotoxins and their relatives. Science (Wash . DC) . 248:705 .